Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

AIMS: To study the effect of CYP2D6*4 on antidepressant dose, switching and discontinuation of therapy. METHODS: The study consisted of all subjects in the Rotterdam Study, who received a first antidepressant prescription between April 1st 1991 and July 1st 2005 and for whom data on CYP2D6 genotype...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bijl, Monique J, Visser, Loes E, Hofman, Albert, Vulto, Arnold G, van Gelder, Teun, Stricker, Bruno H Ch, van Schaik, Ron H N
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2008
Assuntos:
Pharmacogenetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2291379/
https://ncbi.nlm.nih.gov/pubmed/18070221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.03052.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados